Carfilzomib (Intravenous Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Carfilzomib (Intravenous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Kyprolis

Description

Carfilzomib injection is used to treat multiple myeloma (a type of bone marrow cancer) in patients who have received at least 2 prior treatments that did not work well. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Carfilzomib is an antineoplastic agent (cancer medicine).

This medicine is to be administered only by or under the supervision of your doctor.

This product is available in the following dosage forms:

  • Powder for Solution
Before Using
DR603665 Portions of this document last updated: Sept. 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger